View drug registration information details.

Items	Registration information
ID	463
No	463
Brand Name	ESCIVEX 10
Ingredients	Escitalopram 10 mg
Dosage Form	Film coated Tablets
Primary Packaging	Alu-Alu Blister
Storage	Store below 30°C. Protect from light.
Shelf Life	3 YEARS
Pack Size	BOX OF 3 X 10'S
Dispensing Category	PRESCRIPTION
ATC Classification
Pharmaceutical Class	Antidepressants
Indications	Treatment of major depressive episodes, Treatment of panic disorder with or without agoraphobia. ,Treatment of social anxiety disorder (social phobia), Treatment of generalised anxiety disorder, Treatment of obsessive-compulsive disorder
Contraindications	Hypersensitivity to the active substance or to any of the Excipients.  Concomitant treatment with non-selective, irreversible monoamine oxidase inhibitors (MAO-inhibitors) is contraindicated due to the risk of serotonin syndrome with agitation, tremor, hyperthermia etc. The combination of escitalopram with reversible MAO-A inhibitors (e.g.moclobemide) or the reversible non-selective MAO-inhibitor linezolid is contraindicated due to the risk of onset of a serotonin syndrome.  Escitalopram is contraindicated in patients with known QT interval prolongation or congenital long QT syndrome.  Escitalopram is contraindicated together with medicinal products that are known to prolong the QT interval
Side Effects	 Psychiatric disorders: Anxiety, restlessness, abnormal dreams, libido decreased, anorgasmia  Nervous system disorders: Headache, Insomnia, somnolence, dizziness, paraesthesia, tremor  Gastrointestinal disorders: Nausea, Diarrhoea, constipation, vomiting, dry mouth  Reproductive system and breast disorders: ejaculation disorder, impotence, metrorrhagia, menorrhagia
Unit Price
EDL	No
Description	White colour round shape biconvex film coated tablet
Note
License Owner	VE PRODUCTS (LAO) CO.,LTD
Manufacturer	WEST-COAST PHARMACEUTICAL WORKS LTD
Country	INDIA
Import Registration No	G/25/163
Import Registration Date
Activity	CERTIFICATE RELEASED
Applied Date	2024-10-15
FDD Registration No	12 I 5834/24
FDD Registration Date	2024-12-30
Expiry Date	2029-12-29

Back to drug list